© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Expert Interviews
Individualizing UF Therapy
May 06, 2022
Drs Al-Hendy and Lopes conclude with final thoughts on GnRH receptor antagonists, relugolix and elagolix, changing the UF treatment landscape.
Addressing Unmet Needs in UF
May 06, 2022
Dr Al-Hendy discusses what it takes to individualize UF treatment for each patient.
Biden Administration’s Healthcare Priorities and the Build Back Better Act, per Ryan Urgo of Avalere
May 06, 2022
Ryan Urgo, Managing Director, Health Policy at Avalere addressed the Biden administration’s healthcare priorities and if the Build Back Better legislation will include provisions that deal with drug prices? Urgo spoke at this year's annual Asembia Specialty Pharmacy Summit in Las Vegas on the subject, as well.
Jayne Hornung of MMIT Talks Digital Therapeutics at Asembia
May 04, 2022
Jayne Hornung, Chief Clinical Officer, Pharmacy, MMIT addresses the difference between digital therapeutics in the pharmacy and medical benefit space, and digs into the potential causes of the slow uptake in digital therapeutics among payers during this year's Asembia Specialty Pharmacy Summit in Las Vegas.
Doug Long of IQVIA Gives an Outlook on the Specialty Pharmacy Industry at Asembia
May 04, 2022
Doug Long, vice president of Industry Relations at IQVIA spoke on how the current inflationary trend in the economy affects healthcare spending and prices, as well as the trend of specialty drugs accounting for half of the drug spend in healthcare. Hear more of what he shared with our team at this year's Asembia Specialty Pharmacy Summit in Las Vegas.
Jayson Slotnik of Health Policy Strategies, Inc Discusses Value-Based Contracting at Asembia 2022
May 03, 2022
Jayson Slotnik, partner at Health Policy Strategies, Inc, addresses the most recent developments in value-based contracting and how it affects specialty pharmacy at this year's Asembia Specialty Pharmacy Summit in Las Vegas.
Sonia Oskouei of Cardinal Health Discusses the Importance of Interchangeability for Biosimilars
May 03, 2022
Sonia Oskouei, PharmD, vice president of Biosimilars at Cardinal Health, spoke on pharmacists playing a bigger role in driving biosimilar adoption in 2023 and beyond during Asembia's 2022 Specialty Pharmacy Summit in Las Vegas.
Tracy Russell of CoverMyMeds Addresses Efforts Upcoming in Specialty Pharmacy
May 02, 2022
Tracy Russell, senior director of state government affairs at CoverMyMeds addressed what piece of new federal legislation will have the biggest effect on specialty pharmacy and what the Biden administration's emphasis on healthcare equity will do for specialty pharmacy. Russell spoke more on this topic at this year's Asembia Specialty Pharmacy Summit in Las Vegas.
Unmet Needs for UF Treatment
April 29, 2022
Drs Lopes and Al-Hendy describe the unmet needs they see when treating patients with UF.
Healthcare Disparities in Women’s Reproductive Health
April 29, 2022
Dr Maria Lopes provides an overview of common disparities seen when treating and maintaining women’s reproductive health and how these can be minimized.